Company intelligence / Profile preview

Life Length

Madrid, Community of Madrid, Spain

Ownership: Private
Development stage: Commercial

Overview

Life Length’s telomere measurement technologies are commercially available and used globally for clinical diagnostics, research, drug development support, and as biomarkers of biological age. The company’s prostate cancer diagnostic tool received regulatory approval from the Spanish Agency for Medicines and Health Products in 2022. Its TAT® technology has been validated through multiple scientific publications and international partnerships.

Therapeutic areas: OncologyOtherCardiovascularNeurologyWomen's Health
Modalities: Non-pharmacological therapy (diagnostic test/biomarker)Device (diagnostic platform)Biomarkers (as a service/product)
Industry: Molecular Diagnostics

Partnerships

Freiburg Medical Laboratory Middle East LLC/DubaiCleveland HeartLab/U.S.The Doctors Laboratory/U.K.LabCo/Western Europe

Beyond the preview

Go deeper on Life Length.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Life Length.

Explore the full profile